Basic Information
Cinclus Pharma AG is a research-based biotechnology company dedicated to developing small molecule drugs for the treatment of acid-related gastric diseases. Its lead product, X842, has been studied in Phase I clinical trials.
Cinclus Pharma AB
Basel,CantonofBasel-City,Switzerland
unclear
January 01, 2014
info@cincluspharma.com